Sanofi stock ends the day near USD 42.50 at the close
Published on 09/22/2026 at 23:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sanofi stock traded near USD 42.50 on the Nasdaq on September 22, 2026, according to market data cited in a same-day conference report. The U.S.-listed ADRs were near the 52-week low of USD 40.89, while the Nasdaq Composite gained 2.26 percent to 27,122.09 on the same date.
September 22, 2026 session profile
Sanofi SA (ISIN FR0000120578) opened at USD 42.50 on the Nasdaq, according to MarketBeat. The stock was down roughly 9 percent year to date and stood USD 1.61 above its reported 52-week low.
The session followed Sanofi's presentation at the Bank of America Global Healthcare Conference. As Investing.com reported, management outlined a research and development reset, a stricter portfolio review and a target for a nominally 50/50 split between internal and external innovation.
After the bell today
Sanofi's conference update was the main dated corporate development in the session report. Management said the next strategic update is expected with third-quarter earnings in October, when the portfolio and capital allocation plans are due to be discussed, according to Investing.com.
